HomeTown and Schoolfundr Partner to Revolutionize Fundraising for America’s Schools
COLUMBUS, Ohio & MINNEAPOLIS–(BUSINESS WIRE)–HomeTown, the leading K-12 event management and digital ticketing company which supports thousands of... Read more.
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors
BEIJING & BARCELONA, Spain–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global... Read more.
Logitech Sight AI Camera Now Certified for Microsoft Teams and Zoom Rooms
Logitech AI-powered companion camera achieves industry-first certifications; promotes meeting equity in hybrid work environments LAUSANNE, Switzerland & SAN... Read more.
LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform
DUBLIN & MUNICH–(BUSINESS WIRE)–#TAVR–LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and navigation platform, today... Read more.
Marti Warrant Holders Reminded to Tender Warrants Before 12:00 Midnight, Eastern Time on December 19, 2023
ISTANBUL–(BUSINESS WIRE)–Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye’s leading mobility app, today provided... Read more.
Best’s Market Segment Report: AM Best Maintains Negative Outlook on Germany’s Life Insurance Segment
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best is maintaining its outlook for Germany’s life insurance segment at negative. In its new Best’s... Read more.
Best’s Market Segment Report: AM Best Maintains Negative Outlook on Germany’s Non-Life Insurance Segment
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best is maintaining its outlook for Germany’s non-life insurance segment at negative. In its new Best’s... Read more.
Mitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses
The Lineup includes the world’s first 8-inch polymer wafer for AR glasses TOKYO–(BUSINESS WIRE)–Mitsui Chemicals, Inc. (Tokyo: 4183; President &... Read more.
Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)
Preliminary data demonstrate that SENS-401 has a favorable safety profile when administered continuously for up to 11 weeks in adult patients undergoing cisplatin-based... Read more.
Innate Pharma Announces Leadership Change
Current CEO Mondher Mahjoubi to leave Innate Pharma to pursue an opportunity at a large pharmaceutical company Current Chairman of the Supervisory Board, former... Read more.